Why Chemours Gets A Double Upgrade From This Analyst
Why Chemours Gets A Double Upgrade From This Analyst
Chemours Co (NYSE:CC) reported in late March its fourth-quarter earnings ahead of expectations.
科慕公司（紐約證券交易所代碼：CC）在3月下旬公佈的第四季度收益超出預期。
With the company's accounting issue in the rearview mirror, many of its businesses seem to be at or near an inflection point, according to BMO Capital Markets.
根據BMO Capital Markets的數據，隨着該公司的會計問題浮出水面，其許多業務似乎正處於或接近轉折點。
The Chemours Analyst: John McNulty upgraded the rating for Chemours from Underperform to Outperform, while raising the price target from $19 to $34.
科慕分析師：約翰·麥克納爾蒂將科慕的評級從表現不佳上調至跑贏大盤，同時將目標股價從19美元上調至34美元。
The Chemours Thesis: The company announced its first-quarter guidance well below expectations and there was limited visibility into its performance in 2024, McNulty said in the upgrade note.
Chemours論點：麥克納爾蒂在升級說明中表示，該公司公佈的第一季度預期遠低於預期，其2024年的業績知名度有限。
Check out other analyst stock ratings.
查看其他分析師股票評級。
Chemours' earnings should improve through 2024 and into the next couple of years, as the company gets past "one-offs," the analyst stated.
這位分析師表示，隨着Chemours的過去 “一次性”，到2024年以及未來幾年，公司的收益應該會有所改善。
"We expect Chemours to outperform the market as it appears things are at trough/coming off trough right now in all of their segments," he added.
他補充說：“我們預計Chemours的表現將超過市場，因爲目前所有細分市場的情況似乎都處於低谷/即將走出低谷。”
"Finally, our time with CEO Dignam confirmed she has a solid plan to drive the company going forward," McNulty further wrote.
麥克納爾蒂進一步寫道：“最後，我們與首席執行官迪格南在一起的時光證實了她有一個推動公司向前發展的堅實計劃。”
CC Price Action: Shares of Chemours had risen by 3.22% to $27.92 at the time of publication on Tuesday.
CC價格走勢：在週二發佈時，科慕的股價上漲了3.22％，至27.92美元。
Photo: Courtesy Chemours
照片：由 Chemours 提供